Law360, New York (December 09, 2003, 12:00 AM ET) -- The Brazilian government has reportedly issued new threats to break Swiss drugmaker Roche's patent for Viracept (nelfinavir), unless the company concedes a greater price discount on the HIV/AIDS treatment.
The Brazilian government has been playing hardball with multinational drugmakers to bring down the cost of HIV/AIDS drugs. Last month, Merck and Bristol-Myers Squibb both conceded substantial discounts.
However, Roche has been sticking to its guns at the negotiating table, offering a 5-9% discount. The Brazilian health ministry, which last month negotiated a record 76% discount for...
Brazil Threatens to Break Roche's HIV/AIDS Drug Patent
To view the full article, take a free trial now.
